SV

Street Verdict

Analyst Scorecard

A record of what Christy Mathai said publicly, with the source. Not advice.

Pending — not yet graded
“Bullish on the pharma sector, focusing on companies with strong pipelines and reasonable valuations. The fund is finding interesting plays where the incremental growth pipeline is improving, indicating a positive outlook for select pharma names.”
Nifty PharmaBullishCalled 31 Oct 2025
Verdict:PENDING

This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.

Read the original articleSee Christy Mathai’s full track record